P&G Health fixes Aug 27, 2026 as record date for AGM, dividend

procter & gamble health has fixed Thursday, August 27, 2026 as the record date for its 59th Annual General Meeting (AGM) and the payment of final dividend. The company announced that the AGM is scheduled to be held on Thursday, September 3, 2026. Shareholders registered in the records of the company on the record date will be eligible to attend the meeting and receive the dividend, subject to approval by members.

The final dividend payment is contingent upon approval by the shareholders at the ensuing AGM. If approved, the company stated that the dividend will be disbursed to eligible members by September 27, 2026. The notification updates the schedule previously communicated to the stock exchanges.

Key Schedule

Event	Particulars	Revised Date
59th Annual General Meeting	-	Thursday, September 3, 2026
Record date	For the purpose of AGM and payment of final dividend	Thursday, August 27, 2026

The intimation was addressed to the Corporate Relations Department of The BSE Limited and the Listing Department of The National Stock Exchange of India Limited. The filing was signed by Zeal Rupani, Company Secretary of Procter & Gamble Health Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.56%	-3.17%	+2.77%	+22.55%	+10.28%	+19.49%

Procter & Gamble Health Limited has restructured its senior management team to strengthen its commercial and sales leadership, effective July 1, 2026. The company announced the appointment of Shine Matthew Sunny as the new Marketing Strategy and Planning leader, Commercial Excellence & E-commerce Leader, while three existing senior executives have been reassigned to different regional and functional roles.

The reshuffle involves internal organizational changes where Mr. Abhijit Roy, Mr. M. Padmakar Rao, and Mr. Nilesh Barbade will transition to new designations. These adjustments aim to leverage the extensive experience of the leadership team across sales, trade, and institutional business verticals.

Changes in Senior Management Personnel

The following table details the new roles effective July 1, 2026:

Name	Designation as on date	Designation effective July 1	Nature of Change
Mr. Abhijit Roy	Marketing Strategy and Planning leader, E-commerce & Commercial Excellence Leader	Sales Leader (South and East region) and Exports Leader	Role-change
Mr. M. Padmakar Rao	Sales Leader (West and South region)	Sales Leader (North & West region) and Institutional Business Leader	Role-change
Mr. Nilesh Barbade	Sales Leader (North and East region)	Sales Leader (Trade)	Role-change
Mr. Shine Matthew Sunny	-	Marketing Strategy and Planning leader, Commercial Excellence & E-commerce Leader	Appointment

Executive Profiles

Mr. Abhijit Roy brings over 30 years of experience in the Pharma/OTC sector, including 22 years at Merck India. A science graduate from Guwahati University, he has held various sales leadership roles and currently serves as Director of Sales at P&G Health.

Mr. M. Padmakar Rao holds a B.Sc. from Osmania University and a Post Graduate Diploma in Pharmaceutical Business Management. With over 25 years in the pharmaceutical industry, his expertise spans field sales, marketing operations, and trade channel management.

Mr. Nilesh Barbade possesses an MBA from UAS, Dharwad, and a B.Sc. degree. He has over 26 years of experience in the pharmaceutical industry, including leadership roles in sales, institutional business, and distributor operations.

Mr. Shine Matthew Sunny, the new appointee, has a Post-graduate Diploma in Management from IMIS, Bhubaneswar, and a B.Com degree from St. Xavier's College. He brings over 15 years of experience from P&G and Reckitt Benckiser, specializing in sales strategy, commercial excellence, and e-commerce.